Initial body temperature in ischemic stroke: Nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity

Stroke

Volumn 46, Issue 1, 2015, Pages 132-136

  Kim, Seo Hyun ^a   Saver, Jeffrey L ^b  

^a Yonsei University Wonju   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

body temperature; outcome measures; stroke; tissue type plasminogen activator

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

AGED; ARTICLE; BODY TEMPERATURE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANKIN SCALE; TREATMENT OUTCOME; BRAIN; COMPLICATION; FIBRINOLYTIC THERAPY; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; STROKE;

AGED; BODY TEMPERATURE; BRAIN; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84920436411     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006107     Document Type: Article

References (30)

1. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422-425.
2. Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke. 2001;32:413-417.
3. Saini M, Saqqur M, Kamruzzaman A, Lees KR, Shuaib A; VISTA Investigators. Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke. 2009;40:3051-3059.
4. Karaszewski B, Thomas RG, Dennis MS, Wardlaw JM. Temporal profle of body temperature in acute ischemic stroke: relation to stroke severity and outcome. BMC Neurol. 2012;12:123.
5. Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen MT, Thomassen L. The effect of physiologic derangement in patients with stroke treated with thrombolysis. J Stroke Cerebrovasc Dis. 2008;17:141-146.
6. Millán M, Grau L, Castellanos M, Rodríguez-Yáñez M, Arenillas JF, Nombela F, et al. Body temperature and response to thrombolytic therapy in acute ischaemic stroke. Eur J Neurol. 2008;15:1384-1389.
7. Naess H, Idicula T, Lagallo N, Brogger J, Waje-Andreassen U, Thomassen L. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thromboly-sis: the Bergen stroke study. Acta Neurol Scand. 2010;122:414-417.
8. Kvistad CE, Thomassen L, Waje-Andreassen U, Naess H. Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study. Vasc Health Risk Manag. 2012;8:333-338.
9. de Ridder I, den Hertog H, van Gemert M, Dippel D, van der Worp B; PAIS investigators. Increased beneft of alteplase in patients with ischemic stroke and a high body temperature. Cerebrovasc Dis. 2013;35:60-63.
10. Lees JS, Mishra NK, Saini M, Lyden PD, Shuaib A; Virtual International Stroke Trials Archive (VISTA) Collaborators. Low body temperature does not compromise the treatment effect of alteplase. Stroke. 2011;42:2618-2621.
11. Kvistad CE, Thomassen L, Waje-Andreassen U, Logallo N, Naess H. Body temperature and major neurological improvement in tPA-treated stroke patients. Acta Neurol Scand. 2014;129:325-329.
12. van der Worp HB, Macleod MR, Kollmar R; European Stroke Research Network for Hypothermia (EuroHYP). Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab. 2010;30:1079-1093.
13. de Ridder IR, de Jong FJ, den Hertog HM, Lingsma HF, van Gemert HM, Schreuder AH, et al. Paracetamol (acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above. [published online ahead of print May 22, 2013]. Int J Stroke. http://dx.doi.org/10.1111/ijs.12053. Accessed August 15, 2014.
14. Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, et al; QASC Trialists Group. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011;378:1699-1706.
15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
16. Ernon L, Schrooten M, Thijs V. Body temperature and outcome after stroke thrombolysis. Acta Neurol Scand. 2006;114:23-28.
17. Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H. Is higher body temperature benefcial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries? Vasc Health Risk Manag. 2014;10:49-54.
18. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke. 2000;31:2912-2919.
19. Saver JL, Yafeh B. Confrmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. Stroke. 2007;38:414-416.
20. Yenari MA, Palmer JT, Bracci PM, Steinberg GK. Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res. 1995;77:475-481.
21. Shaw GJ, Bavani N, Dhamija A, Lindsell CJ. Effect of mild hypothermia on the thrombolytic effcacy of 120 kHz ultrasound enhanced thromboly-sis in an in-vitro human clot model. Thromb Res. 2006;117:603-608.
22. Shaw GJ, Dhamija A, Bavani N, Wagner KR, Holland CK. Arrhenius temperature dependence of in vitro tissue plasminogen activator throm-bolysis. Phys Med Biol. 2007;52:2953-2967.
23. Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H. Persistent middle cerebral artery occlusion associated with lower body temperature on admission. Vasc Health Risk Manag. 2013;9:297-302.
24. Bukur M, Kurtovic S, Berry C, Tanios M, Ley EJ, Salim A. Pre-hospital hypothermia is not associated with increased survival after traumatic brain injury. J Surg Res. 2012;175:24-29.
25. Takagi K, Tsuchiya Y, Okinaga K, Hirata M, Nakagomi T, Tamura A. Natural hypothermia immediately after transient global cerebral ischemia induced by spontaneous subarachnoid hemorrhage. J Neurosurg. 2003;98:50-56.
26. Dabzl D. Chapter 19. Hypothermia and frostbite. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 18th ed. New York, NY: McGraw-Hill; 2012. http://accessmedicine.mhmedical.com/content.aspx?bookid=331 &Sectionid=40726729. Accessed May 10, 2014.
27. Konstantinidis A, Inaba K, Dubose J, Barmparas G, Talving P, David JS, et al. The impact of nontherapeutic hypothermia on outcomes after severe traumatic brain injury. J Trauma. 2011;71:1627-1631.
28. Hilz MJ, Moeller S, Akhundova A, Marthol H, Pauli E, De Fina P, et al. High NIHSS values predict impairment of cardiovascular autonomic control. Stroke. 2011;42:1528-1533.
29. Steiner AA, Branco LG. Hypoxia-induced anapyrexia: implications and putative mediators. Annu Rev Physiol. 2002;64:263-288.
30. Karaszewski B, Carpenter TK, Thomas RG, Armitage PA, Lymer GK, Marshall I, et al. Relationships between brain and body temperature, clinical and imaging outcomes after ischemic stroke. J Cereb Blood Flow Metab. 2013;33:1083-1089.